MFC-1040

N/A

Report date: 2024/12/05 17:35:06
NMEFirst In Class

Base Information

Drug NameMFC-1040
Drug Alias NameMFC-1040
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsPulmonary Arterial HypertensionAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApaxen SAMifcare
China Registration ClassN/A

Develop Information

Active CompaniesMifcareApaxen SA
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial HypertensionAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A